ArticleOncogene2025

A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway.

Linya Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.